Primer and method for detecting and typing the CbtA / CbeA toxin-antitoxin system of Salmonella Indiana

By designing specific PCR detection methods and primers, the problem of difficult to quickly detect and type Salmonella Indiana toxin-antitoxin system in the prior art is solved, and the rapid, sensitive and specific detection of the system is achieved and Typed, suitable for batch applications.

CN118360421BActive Publication Date: 2024-11-22JIANGSU INST OF POULTRY SCI
View PDF 7 Cites 0 Cited by

Patent Information

Application Number
CN202410623281.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-05-20
Publication Date
2024-11-22
Estimated Expiration
2044-05-20

AI Technical Summary

Technical Problem

The prior art is difficult to detect and type the CbtA/CbeA toxin-antitoxin system quickly and effectively, which has affected the study of the pathogenicity and evolutionary laws of the bacteria.

Method used

A PCR detection method for the Salmonella Indiana CbtA/CbeA toxin-antitoxin system was designed, and PCR reactions were performed using specific primers to achieve rapid, specific, and high sensitivity detection and typing by adjusting reaction conditions and procedures.

Benefits of technology

It has achieved rapid identification and typing of the Indiana Salmonella CbtA/CbeA toxin-antitoxin system, and can distinguish between complete and defective types in one reaction. It has high detection sensitivity and cost advantages, and is suitable for batch testing.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118360421B_ABST
    Figure CN118360421B_ABST
Patent Text Reader

Abstract

The present invention discloses a primer and method for detecting and typing the CbtA / CbeA toxin-antitoxin system of Indiana Salmonella. The present invention establishes a method for rapid detection and typing by analyzing different genotype sequences of the CbtA / CbeA toxin-antitoxin system of Indiana Salmonella. The invention has the advantages of being rapid, simple, highly specific and highly sensitive. Through a one-step reaction, the Indiana Salmonella CbtA / CbeA toxin-antitoxin system can be rapidly detected and typed. Compared with the whole genome sequencing analysis method, the invention has a great advantage in detection time and detection cost, is suitable for batch detection, and is expected to have broad application prospects in the research field of the Indiana Salmonella CbtA / CbeA toxin-antitoxin system.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of molecular detection, and particularly relates to a primer for detecting and typing the CbtA / CbeA toxin-antitoxin system of Indiana Salmonella and its application. Background Art

[0002] In recent years, multi-drug resistant Indiana Salmonella has begun to spread widely in my country. It has become an important serotype second only to Enteritidis Salmonella in some meat-eating poultry and raw meat products, surpassing several other common serotypes (Salmonella Typhimurium, Salmonella Delpy, Salmonella Agona, etc.). Many studies have shown that Indiana Salmonella is closely related to vomiting, diarrhea, fever, gastroenteritis, local infection and other diseases in humans and animals. At present, the widespread prevalence of Indiana Salmonella in my country has attracted great attention in the fields of livestock and poultry breeding, food safety, and public health.

[0003] The bacterial toxin-antitoxin system (TAS) consists of two co-expressed genes, one of which encodes a toxin and the other encodes an antitoxin. TAS was first discovered in some low-copy plasmids. Its function is usually to maintain the stability of the plasmid in the bacterial community. When the plasmid is lost in the progeny bacteria, the antitoxin will be rapidly decomposed by the protease to produce free toxins, thereby killing the progeny bacteria that do not retain the plasmid. Subsequent studies have found that TAS is also widely present in the chromosomes of various bacteria. Under environmental stimulation or stress, the antitoxin is degraded or consumed by the protease. After the toxin is released, it interferes with or changes the cell's DNA replication, ATP and cell wall synthesis, leading to cell growth inhibition, death, and the formation of persisters. TAS can enable bacteria to maintain population continuity under stressful environments, so it is of great significance.

[0004] Analysis of the Indiana Salmonella genome revealed that a type IV TAS, CbtA / CbeA (CbtA, cytoskeletonBindingToxinA, cytoskeleton binding toxin A; CbeA, cytoskeletonbundling-enhancing factorA, cytoskeleton bundling enhancing factor A), is commonly found in the current epidemic strains in my country. The mechanism of action of CbtA / CbeA is that the toxin CbtA acts on cytoskeleton proteins (FtsZ and MreB), thereby inhibiting cell division, while the antitoxin CbeA inhibits toxicity by competing with CbtA for cellular targets. This TAS is mainly reported in Escherichia coli and is almost absent in other serotypes of Salmonella. The amino acid sequence analysis of Indiana Salmonella CbtA / CbeA-TAS found that the antitoxin YeeU is relatively conservative, but there is variation in YeeV. According to the length of the toxin YeeV, it is divided into two types: complete type (containing 128 amino acids) and defective type (containing 90 amino acids). At present, there is almost no research on the biological functions of these two types of genotypes of CbtA / CbeA-TAS. The applicant's previous research showed that these two types of genotypes of CbtA / CbeA-TAS are not only closely related to the genetic evolution of Indiana Salmonella, but also have different effects on the pathogenicity of the pathogen. Therefore, studying the carrying of different genotypes of CbtA / CbeA-TAS in Indiana Salmonella is of great significance for further analyzing the evolution of pathogens and studying pathogenicity. Studies on a few publicly available Indiana Salmonella genomes have found that some strains also contain different genotypes of CbtA / CbeA at the same time. In order to study the distribution of different genotypes of CbtA / CbeA-TAS in Indiana Salmonella, the inventors of the present invention established a method for rapid detection and typing by analyzing the genome sequence of Indiana Salmonella, which provided important technical support for further research on CbtA / CbeA-TAS. Summary of the invention

[0005] In order to overcome the shortcomings and deficiencies of the prior art, the primary purpose of the present invention is to provide a primer for detecting and typing the CbtA / CbeA toxin-antitoxin system of Salmonella Indiana.

[0006] Another object of the present invention is to provide a PCR method for detecting and typing the CbtA / CbeA toxin-antitoxin system of Salmonella Indiana. The method has the characteristics of simple and rapid operation, strong specificity, high sensitivity and low cost, and can be widely used in the detection and typing research of CbtA / CbeA-TAS.

[0007] The purpose of the present invention is achieved through the following technical solutions:

[0008] A PCR primer for detecting and typing the CbtA / CbeA toxin-antitoxin system of Indiana Salmonella, the nucleotide sequence of which is as follows:

[0009] Upstream primer: 5′-CTGCACCGTGACGCCCTGTT-3′;

[0010] Downstream primer 1: 5′-ATGCCTCCCGTACGTGTGTG-3′;

[0011] Downstream primer 2: 5′-GGTAATGTTATTTACCGTTCTG-3′.

[0012] Furthermore, the components of the PCR detection system are as follows: each 25 μl reaction solution includes 2.5 μl of 10×PCR buffer, 2 μl of dNTPs, 0.25 μl of Taq DNA polymerase, 3 μl of detection primers, 1-2 μl of DNA template and an appropriate amount of sterile double distilled water.

[0013] Furthermore, the preparation method of the PCR detection method is as follows: pre-denaturation at 94°C for 5 minutes; denaturation at 94°C for 30 seconds; annealing at 58°C for 30 seconds; extension at 72°C for 30 seconds; a total of 30 cycles, and finally extension at 72°C for 8 minutes.

[0014] Furthermore, the 10×PCR buffer contains 100 mM KCl, 80 mM (NH 4 ) SO 4 , 100 mM Tris-HCl with a pH of 9.0, 15 mM MgCl 2 , and 0.5% Tergitol-type NP-40.

[0015] Furthermore, the primer concentration is 10 μM.

[0016] Furthermore, the dNTPs include dGTP, dCTP, dATP, and dTTP, and the concentration of each component is 2.5 mM.

[0017] Furthermore, the kit does not include other primers. Furthermore, a PCR method for detecting and typing the CbtA / CbeA toxin-antitoxin system of Salmonella Indiana comprises the following steps:

[0018] S1: Use the boiling method or commercial kit to extract bacterial genomic DNA to obtain the detection template.

[0019] S2: PCR amplification, add 10× PCR buffer, dNTPs, Taq DNA polymerase, detection primer set and DNA template into a sterile PCR reaction tube, add sterile double distilled water to a total volume of 25 μl, set up positive, negative and blank controls, and use a PCR instrument to perform amplification reaction; use 2% agarose gel electrophoresis to perform electrophoresis detection on the amplified products and analyze the results;

[0020] The primers of the primer set include:

[0021] Upstream primer: 5′-CTGCACCGTGACGCCCTGTT-3′;

[0022] Downstream primer 1: 5′-ATGCCTCCCGTACGTGTGTG-3′;

[0023] Downstream primer 2: 5′-GGTAATGTTATTTACCGTTCTG-3′.

[0024] Compared with the prior art, the present invention has the following beneficial effects:

[0025] The present invention can quickly identify and type the CbtA / CbeA toxin-antitoxin system of Indiana Salmonella through one reaction, that is, the appearance of a 390bp band indicates that a defective CbtA / CbeA toxin-antitoxin system is contained; the appearance of a 738bp band indicates that a complete CbtA / CbeA toxin-antitoxin system is contained; the appearance of two bands of 390bp and 738bp indicates that both complete and defective CbtA / CbeA toxin-antitoxin systems are contained. It also has great advantages in detection time and detection cost, and is suitable for batch detection. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 This is a specific screening diagram of different primer sets for Indiana Salmonella CbtA / CbeA-TAS. In the figure: lanes 1, 6, and 11 are DNA molecular weight standard markers (100-2000bp), lanes 2-4 are the test results of primer set 1 (the order is complete type, defective type, complete type + defective type, the same below), lanes 7-9 are the test results of primer set 2, lanes 12-14 are the test results of primer set 3, and lanes 5, 10, and 15 are negative controls.

[0027] Figure 2This is a sensitivity comparison chart of different primer sets for Indiana Salmonella CbtA / CbeA-TAS. In the figure: lanes 1, 8, and 15 are DNA molecular weight standard Markers (100-2000bp), lanes 2-7 are the test results of primer set 1 (the concentrations of defective and complete plasmids are 250,000, 25,000, 2500, 250, 25, and 2.5 copies / reaction, respectively, the same below), lanes 9-14 are the test results of primer set 2, lanes 16-21 are the test results of primer set 3, and lane 22 is a negative control.

[0028] Figure 3 It is the sensitivity test result of the method of the present invention. In the figure: lanes 1, 8, and 15 are DNA molecular weight standard markers (100-2000bp), lanes 2, 9, and 16 are standard samples with a concentration of 50,000 copies / reaction (the order is defective type, complete type, defective type + complete type, the same below), lanes 3, 10, and 17 are standard samples with a concentration of 5000 copies / reaction, lanes 4, 11, and 18 are standard samples with a concentration of 500 copies / reaction, lanes 5, 12, and 19 are standard samples with a concentration of 50 copies / reaction, lanes 6, 13, and 20 are standard samples with a concentration of 5 copies / reaction, and lanes 7, 14, and 21 are negative controls.

[0029] Figure 4 This is the specific detection result of the method of the present invention. In the figure: lane M is a DNA molecular weight standard Marker (100-2000bp), lane 1 is a negative control, lane 2 is S1467 (containing complete + defective CbtA / CbeA-TAS), lane 3 is S1017 (containing only one complete CbtA / CbeA-TAS), and lane 4 is S0932 (containing only one defective CbtA / CbeA-TAS).

[0030] Figure 5 The results of detection and typing of some clinical strains. In the figure: Lane M is a DNA molecular weight standard Marker (100-2000bp), Lanes 1, 2, 5, 6, 8, and 10 are strains containing only complete CbtA / CbeA-TAS, Lane 3 is a strain containing only defective CbtA / CbeA-TAS, Lanes 4 and 9 are strains containing both complete and defective CbtA / CbeA-TAS, and Lane 11 is a negative control. DETAILED DESCRIPTION

[0031] The present invention is further described below in conjunction with the embodiments and drawings. The following description is only a preferred embodiment of the present invention and does not limit the present invention in other forms. Any technician familiar with the profession may use the above disclosed technical content to change it into an equivalent embodiment with equivalent changes. Any simple modification or equivalent change made to the following embodiments based on the technical essence of the present invention without departing from the content of the present invention is within the protection scope of the present invention.

[0032] Example 1 Screening and establishment of a method for detecting and typing CbtA / CbeA-TAS of Salmonella Indiana

[0033] According to the CbtA / CbeA-TAS sequences of different genotypes of Indiana Salmonella in GenBank, three sets of detection and typing primers were designed. The nucleotide sequences of the primers are shown in Table 1 (the product sizes from top to bottom represent the amplification sizes of defective CbtA / CbeA and intact CbtA / CbeA, respectively).

[0034] Table 1. Screening of primer sets for detection and typing of Salmonella Indiana CbtA / CbeA-TAS

[0035]

[0036] Detection template: Two genotypes of Indiana Salmonella CbtA / CbeA-TAS sequences (the sequences covered the PCR amplification region) were synthesized by Sangon Biotech (Shanghai) Co., Ltd. The synthesized sequences were diluted into three types of CbtA / CbeA test templates: complete, defective, and complete + defective. The negative control was sterile double distilled water.

[0037] The reagents include: 10×PCR buffer (its components include 100mM KCl, 80mM (NH4)SO4, 100mM Tris-HCl with a pH of 9.0, 15mM MgCl2 and 0.5% Tergitol-type NP-40), dNTPs (including dGTP, dCTP, dATP, dTTP, and the concentration of each component is 2.5mM), Taq DNA polymerase (2.5U / μl), and a detection primer set.

[0038] Detection system and amplification procedure: The detection system is 25 μl, including: 2.5 μl 10×PCR buffer, 2 μl dNTPs, 0.25 μl Taq DNA polymerase, 3 μl detection primer set, 2 μl DNA template and an appropriate amount of sterile double distilled water. The steps of the amplification procedure include: 94°C pre-denaturation for 5 min, 94°C denaturation for 30 s, 58°C annealing for 30 s, 72°C extension for 30 s, a total of 30 cycles, and finally 72°C extension for 8 min; after the reaction, the amplified product was taken out and stored at 4°C.

[0039] Determination of test results: Take 5μl of amplified product, add 1μl 6× Loading buffer and mix well, spot it in the wells of 2% agarose gel electrophoresis plate, 100V voltage, electrophoresis for 40min, and take pictures under gel imager for determination. Recover the amplified product and clone it into pMD-19T vector, pick positive clones for sequencing, and compare the results with known sequences.

[0040] Combination Figure 1 The specific results of different primer sets showed that the three designed primer sets can amplify different genotypes of CbtA / CbeA (the sequencing results are consistent with the original sequence), but there is a certain non-specific amplification phenomenon in the second and third primer sets. In addition, the size of the two genotypes of CbtA / CbeA products amplified by the first primer set is significantly different (348bp), which is better than the second primer set (269bp) and the third primer set (246bp), and is easier to distinguish. Therefore, from the amplification results of different primer sets, it was found that the specificity of the first primer set was significantly better than that of the second and third primer sets.

[0041] The absolute number of gene copies contained in the composite was further calculated based on the molecular weight and absolute weight of the composite and DNA quantification technology. The composite was then diluted to prepare composites containing the same concentration of complete and defective types. The dilution reagent concentrations of each 25 μl composite were 250,000 copies, 25,000 copies, 2,500 copies, 250 copies, 25 copies, and 2.5 copies, respectively. The negative control was sterile double distilled water. The sensitivity of different primer sets was compared by PCR amplification and agarose gel electrophoresis. The results are shown in Figure 2 ,It can be seen from the figure that the sensitivity of the first group of primers can reach 25 copies, which is better than the 2.5 copies of the second and third groups of primers.

[0042] comprehensive Figure 1 and Figure 2 Based on the results, the first group of primers was selected as the detection and typing primers for the Indiana Salmonella CbtA / CbeA toxin-antitoxin system of the present invention.

[0043] Example 2 Sensitivity test experiment

[0044] The sensitivity of the present invention was evaluated using the method of Example 1. The absolute number of gene copies contained in the synthetic compound was calculated based on the molecular weight and absolute weight of the synthetic compound and the DNA quantification technique. Subsequently, the synthetic compound was diluted to prepare dilution reagents containing 50,000 copies, 5,000 copies, 500 copies, 50 copies, and 5 copies per 25 μl of the synthetic compound. The method of Example 1 was used to amplify three CbtA / CbeA templates containing different concentrations of complete, defective, and complete+defective types, and the sensitivity of the present invention was determined in turn. The negative control was sterile double distilled water. The results are shown in Table 1. Figure 2 .from Figure 2 It can be seen that the minimum detection limit of the intact type, defective type, and intact type + defective type in the detection method of the present invention is 50 copies, which has good detection sensitivity.

[0045] Example 3 Specificity evaluation experiment

[0046] The specificity of the present invention was evaluated by the method of Example 1. The S1467 strain containing both complete and defective CbtA / CbeA was selected (Gong et al., Genomic Characterization of a Plasmid-Free and Highly Drug-Resistant Salmonella enterica Serovar Indiana Isolate in China. Vet Sci. 2024, 11(1):46), S1017 strain containing only complete CbtA / CbeA (the strain has been recorded in the applicant's prior application CN202410576594.4, the application date is May 10, 2024, and the invention name is a strain of Indiana Salmonella S1017 and its application) and S0932 strain containing only defective CbtA / CbeA (the strain has been recorded in the applicant's prior application CN202410576626.0, the application date is May 10, 2024, and the invention name is a strain of Indiana Salmonella S0932 and its application). After overnight culture in broth, bacterial genomic DNA was extracted using a commercial kit, and amplification reaction was performed according to the method of Example 1. The negative control was sterilized double distilled water. The results are shown in Table 1. Figure 3 .Depend on Figure 3 It can be seen that strains containing different genotypes of CbtA / CbeA all amplified specific bands: S1467 (390bp+738bp), S1017 (738bp), S0932 (390bp), which is consistent with the expected results. The above results show that the method established by the present invention has good specificity.

[0047] Example 4 CbtA / CbeA Detection and Typing of Clinical Isolates of Salmonella Indiana

[0048] The 237 clinical isolates of Indiana Salmonella preserved by the research group were cultured in broth overnight, and the bacterial genomic DNA was extracted by boiling method. The detection and typing were carried out according to the method of Example 1. The negative control was sterile double distilled water. The detection results of some isolates are as follows: Figure 4 The results showed that the method detected 6 strains containing only defective CbtA / CbeA, 173 strains containing only complete CbtA / CbeA, 19 strains containing both complete and defective CbtA / CbeA, and 39 strains containing no CbtA / CbeA. Compared with the whole genome sequencing analysis method, the present invention has great advantages in detection time and detection cost, and is more suitable for batch detection and typing.

[0049] The present invention and its embodiments are described schematically above, and the description is not restrictive. The drawings show only one embodiment of the present invention, and the actual structure is not limited thereto. Therefore, if a person skilled in the art is inspired by it and designs a structural method and an embodiment similar to the technical solution without creativity without departing from the purpose of the invention, they shall all fall within the protection scope of the present invention.

Claims

1. A primer for detecting and typing the CbtA / CbeA toxin-antitoxin system of Salmonella Indiana, characterized in that: The primer nucleotide sequences are as follows: Upstream primer: 5′-CTGCACCGTGACGCCCTGTT-3′; Downstream primer 1: 5′-ATGCCTCCCGTACGTGTGTG-3′; Downstream primer 2: 5′-GGTAATGTTATTTACCGTTCTG-3′.

2. A method for detecting and typing the CbtA / CbeA toxin-antitoxin system of Salmonella Indiana for non-diagnostic purposes, characterized in that: The components of the detection and typing system are as follows: each 25 μl reaction solution includes 2.5 μl of 10×PCR buffer, 2 μl of dNTPs, 0.25 μl of Taq DNA polymerase, 3 μl of detection primers, 1-2 μl of DNA template and an appropriate amount of sterile double distilled water; the positive control is a plasmid containing the complete and defective CbtA / CbeA toxin-antitoxin system gene sequences of Salmonella Indiana, and the negative control is sterile double distilled water; the detection primers are the primers described in claim 1; The method comprises the following steps: S1: Extract bacterial genomic DNA; S2: Using bacterial genomic DNA as template, add 10× PCR buffer, dNTPs, Taq DNA polymerase, detection primer set and DNA template into a sterile PCR reaction tube, add sterile double distilled water to a total volume of 25 μl, set up positive and negative controls, and use a PCR instrument to perform amplification reaction; The amplified products were detected and analyzed by 2% agarose gel electrophoresis; According to the agarose gel electrophoresis results of the PCR product, the appearance of a 390bp band indicates that it contains a defective CbtA / CbeA toxin-antitoxin system; the appearance of a 738bp band indicates that it contains a complete CbtA / CbeA toxin-antitoxin system; the appearance of two bands of 390bp and 738bp indicates that it contains both complete and defective CbtA / CbeA toxin-antitoxin systems.

3. The method for detecting and typing the CbtA / CbeA toxin-antitoxin system according to claim 2, characterized in that: The primer concentrations were all 10 μM, and equal volumes were mixed to obtain a detection primer set.

4. The method for detecting and typing the CbtA / CbeA toxin-antitoxin system according to claim 2, characterized in that: The dNTPs include dGTP, dCTP, dATP, and dTTP, and the concentration of each component is 2.5 mM.

Citation Information

Patent Citations

  • Salmonella Indiana S1017 and application thereof

    CN118480466A

  • Salmonella Indiana S0932 and application thereof

    CN118480467A

  • Salmonella Indiana PCR (polymerase chain reaction) detection kit and non-diagnosis detection method thereof

    CN107988405A

  • Primer probe combination and kit for simultaneously detecting enterotoxigenic escherichia coli and salmonella and application

    CN114350829A

  • Isothermal amplification primer pair for rapidly detecting salmonella and kit and application thereof

    CN116200510A